Viewing Study NCT00850850


Ignite Creation Date: 2025-12-24 @ 4:48 PM
Ignite Modification Date: 2025-12-30 @ 2:29 AM
Study NCT ID: NCT00850850
Status: UNKNOWN
Last Update Posted: 2010-05-27
First Post: 2009-02-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Physostigmine After General Anesthesia
Sponsor: Bispebjerg Hospital
Organization:

Study Overview

Official Title: The Use of Physostigmine in Elderly Patients in the Postoperative Recovery-phase After General Anesthesia
Status: UNKNOWN
Status Verified Date: 2010-05
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Recovery after general anaesthesia is often prolonged in the elderly. This group is particularly exposed to post-operative confusion. This has negative personal consequences as well as consequences for the postoperative care for these patients.

The hypothesis is that physostigmine will decrease the amount of time in the post-anaesthesia care unit (PACU ), the postoperative amount of pain and shivering and finally post-operative confusion.
Detailed Description: The researchers wish to investigate the use of physostigmine in the elderly patients (age \> 60 yrs, ASA I-III) in the postoperative recovery-phase after general anesthesia.

Apart from the beneficial effects for the patient, the lessened amount of time in the PACU will release caregiving resources and thereby increase the efficacy of the PACU.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: